U.S. Markets closed

Roche to invest CHF 800M expanding manufacturing network

Roche announced plans to invest 800M Swiss francs within its manufacturing network to increase production capabilities for its biologic medicines over the next five years. The investment will be spread across sites in Germany, Switzerland, as well as Vacaville and Oceanside in the USA. Approximately 500 new jobs are expected to be created in conjunction with the facility expansions.